Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical high risk for psychosis: gender differences in symptoms and social functioning.
Rietschel L, Lambert M, Karow A, Zink M, Müller H, Heinz A, de Millas W, Janssen B, Gaebel W, Schneider F, Naber D, Juckel G, Krüger-Özgürdal S, Wobrock T, Wagner M, Maier W, Klosterkötter J, Bechdolf A; PREVENT study group. Rietschel L, et al. Among authors: janssen b. Early Interv Psychiatry. 2017 Aug;11(4):306-313. doi: 10.1111/eip.12240. Epub 2015 Mar 24. Early Interv Psychiatry. 2017. PMID: 25808791
Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment.
Bechdolf A, Wagner M, Veith V, Ruhrmann S, Pukrop R, Brockhaus-Dumke A, Berning J, Stamm E, Janssen B, Decker P, Bottlender R, Moller HJ, Gaebel W, Maier W, Klosterkotter J. Bechdolf A, et al. Among authors: janssen b. Early Interv Psychiatry. 2007 Feb;1(1):71-8. doi: 10.1111/j.1751-7893.2007.00013.x. Early Interv Psychiatry. 2007. PMID: 21352110 Clinical Trial.
Coping as a predictor of treatment outcome in people at clinical high risk of psychosis.
Kommescher M, Wagner M, Pützfeld V, Berning J, Janssen B, Decker P, Bottlender R, Möller HJ, Gaebel W, Maier W, Klosterkötter J, Bechdolf A. Kommescher M, et al. Among authors: janssen b. Early Interv Psychiatry. 2016 Feb;10(1):17-27. doi: 10.1111/eip.12130. Epub 2014 Feb 25. Early Interv Psychiatry. 2016. PMID: 24612629 Clinical Trial.
Prevalence of metabolic syndrome in female and male patients at risk of psychosis.
Cordes J, Bechdolf A, Engelke C, Kahl KG, Balijepalli C, Lösch C, Klosterkötter J, Wagner M, Maier W, Heinz A, de Millas W, Gaebel W, Winterer G, Janssen B, Schmidt-Kraepelin C, Schneider F, Lambert M, Juckel G, Wobrock T, Riedel M, Moebus S. Cordes J, et al. Among authors: janssen b. Schizophr Res. 2017 Mar;181:38-42. doi: 10.1016/j.schres.2016.09.012. Epub 2016 Oct 14. Schizophr Res. 2017. PMID: 27751654 Clinical Trial.
Negative schemata about the self and others and paranoid ideation in at-risk states and those with persisting positive symptoms.
Müller H, de Millas W, Gaebel W, Herrlich J, Hasan A, Janssen B, Juckel G, Karow A, Kircher T, Kiszkenow-Bäker S, Klingberg S, Klosterkötter J, Krüger-Özgürdal S, Lambert M, Lautenschlager M, Maier W, Michel TM, Mehl S, Müller BW, Pützfeld V, Rausch F, Riedel M, Sartory G, Schneider F, Wagner M, Wiedemann G, Wittorf A, Wobrock T, Wölwer W, Zink M, Bechdolf A. Müller H, et al. Among authors: janssen b. Early Interv Psychiatry. 2018 Dec;12(6):1157-1165. doi: 10.1111/eip.12433. Epub 2017 May 19. Early Interv Psychiatry. 2018. PMID: 28524542
Predictors of treatment response to psychological interventions in people at clinical high risk of first-episode psychosis.
Wessels H, Wagner M, Kuhr K, Berning J, Pützfeld V, Janssen B, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, Maier W, Klosterkötter J, Bechdolf A. Wessels H, et al. Among authors: janssen b. Early Interv Psychiatry. 2019 Feb;13(1):120-127. doi: 10.1111/eip.12460. Epub 2017 Jul 4. Early Interv Psychiatry. 2019. PMID: 28675695 Clinical Trial.
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Bechdolf A, Müller H, Stützer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brüne M, Krüger-Özgürdal S, Wobrock T, Riedel M, Klosterkötter J; PREVENT study group. Bechdolf A, et al. Among authors: janssen b. Schizophr Bull. 2011 Sep;37 Suppl 2:S111-21. doi: 10.1093/schbul/sbr083. Schizophr Bull. 2011. PMID: 21860040 Free PMC article. Clinical Trial.
[Neuropsychological Functioning as a Predictor of Treatment Response to Psychoeducational, Cognitive Behavioral Therapy in People at Clinical High Risk of First Episode Psychosis].
Wessels H, Wagner M, Frommann I, Berning J, Pützfeld V, Janssen B, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, Maier W, Klosterkötter J, Bechdolf A. Wessels H, et al. Among authors: janssen b. Psychiatr Prax. 2015 Sep;42(6):313-9. doi: 10.1055/s-0035-1552713. Epub 2015 Aug 26. Psychiatr Prax. 2015. PMID: 26308457 Clinical Trial. German.
The German Research Network on Schizophrenia--impact on the management of schizophrenia.
Wölwer W, Baumann A, Bechdolf A, Buchkremer G, Häfner H, Janssen B, Klosterkötter J, Maier W, Möller HJ, Ruhrmann S, Gaebel W. Wölwer W, et al. Among authors: janssen b. Dialogues Clin Neurosci. 2006;8(1):115-21. doi: 10.31887/DCNS.2006.8.1/wwoelwer. Dialogues Clin Neurosci. 2006. PMID: 16640122 Free PMC article. Review.
603 results